The Economist’s War on Cancer 2015 will bring bring together the most influential leaders in oncology from around Europe to explore and shape the dialogue on cancer. Join pharmaceutical, health care, scientific and government specialists on October 20th 2015 to discuss the leading initiatives in policy and financing, innovation in prevention, treatment and diagnosis and new methods of community engagement. The Summit is sponsored by Merck Serono, Novartis Oncology, EY, Varian Medical Systems and Elekta.
Henrik Lund (Chairman of the board) and Giske Ursin (CEO of Norwegian Cancer Registry) will be present at the event. Oslo Cancer Cluster member companies are entitled to a 25% discount on the delegate registration fee.
For more information on how you can participate:
Contact: Marcia Brissett, Delegate Liaison Officer // Email: firstname.lastname@example.org //Tel: 0044 (0) 207 576 8155
Key topics and confirmed speakers include:
-Towards a Unified European Oncology Framework, led by John Ryan, Acting Director – Public Health Directorate Health and Food Safety Directorate General, European Commission
-Creating a Virtuous Circle in Disease Research and Development, led by Peter Lebowitz, Head of Global Oncology Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
-The Regulatory Perspective: Rallying The European Community Behind a Multi-Stakeholder Adaptive Licensing Approach, led by Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
-A Vision for the future—Cancer Care In 2030, led by Patrick Soon-Shiong, Chairman and Chief Executive Officer, NantWorks
Who should attend:
CEO’s, Presidents, Vice Presidents, Directors and Heads of leading Pharmaceutical, Health Care, Technology and Service Providers whose responsibilities include:
Oncology, Research, Policy, Strategy, Planning, Government Affairs, Innovation, Medicine
Other Attendance groups: Governments, NGO’s, Scientists, Academics, Charities.